DASABUVIR | DASABUVIR | ATC J05AX16 ATC J05AX66 ATC J05AP09 ATC J05AP52
ANTIINFECTIVES TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) HEPATITIS C VIRUS NON-NUCLEOSIDE NS5B PALM POLYMERASE INHIBITOR | ORAL | Cmax 1.35 MICROMOLAR Tmax 4.5 HOUR F 70 PERCENT VD 396 LITER PPB 99.5 PERCENT Cl 47.7 LITER / HOUR (EQN) HT 5.75 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | HCV NON-NUCLEOSIDE NS5B PALM POLYMERASE | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE INHIBITOR CHEMBL5375 HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE Q8JXU8 NS5B PROTEIN HEPATITIS C VIRUS ENZYME TRANSFERASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |